Lapatinib | High-Quality Pharmaceutical Reference Standard
Lapatinib API is a dual tyrosine kinase inhibitor targeting HER2 (ErbB2) and EGFR, used in the treatment of HER2-positive metastatic breast cancer. It works by inhibiting intracellular phosphorylation pathways involved in tumor cell proliferation. Lapatinib API is produced under GMP standards and is suitable for oral tablet formulations.
Lapatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 4
